Tin tức & Cập nhật

IMD is a serious and life-threatening fungal infection and its clinical manifestations are like bacterial pneumonia. Patients with prolonged neutropenia, chronic obstructive pulmonary disease (COPD) or severe viral infection, HIV and CMV reactivation, uncontrolled diabetes mellitus, liver and solid tumors and receiving organ transplant are at risk of developing IMD. Early recognition of the disease and providing life-saving treatment will significantly reduce the mortality and improve patient outcomes. To learn more about Fungal Disease Awareness, please view the video and click this link: https://ph-mims.com/fdaw2020.

The triplet combination of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is as good as dolutegravir + emtricitabine/tenofovir disoproxil fumarate (DTG+F/TDF) in terms of efficacy for HIV control but results in better hepatitis B virus (HBV) outcomes in patients with HIV/HBV co-infection, according to results of the phase III ALLIANCE trial presented at IAS 2022.

People living with HIV (PLWH) who were diagnosed with COVID-19 had a 35-percent higher risk of a major cardiovascular (CV) event in the following year than PLWH without COVID in a Spanish study.

Treatment with dolutegravir during pregnancy does not appear to pose an excess risk of adverse birth outcomes, according to two studies presented at the 24th International AIDS Conference in Montreal, Canada.